A. Adams

发表

Oxo pyrazoline spiro oxiranes a new class of reactive hetero cycles

D. Lankin, S. Eḡe, A. Adams, 1983 .

A Potent Synthetic LXR Agonist Is More Effective than Cholesterol Loading at Inducing ABCA1 mRNA and Stimulating Cholesterol Efflux*

D. Moller, Gaochao Zhou, S. Wright, 2002, The Journal of Biological Chemistry.

O-Arylmandelic acids as highly selective human PPAR α/γ agonists

J. Berger, D. Moller, Gaochao Zhou, 2003 .

Peroxisome Proliferator-Activated Receptor (PPAR)-α Agonism Prevents the Onset of Type 2 Diabetes in Zucker Diabetic Fatty Rats: A Comparison with PPARγ Agonism

J. Berger, D. Moller, T. Doebber, 2006 .

Lithocholic Acid Decreases Expression of Bile Salt Export Pump through Farnesoid X Receptor Antagonist Activity*

S. Wright, P. Meinke, Jinghua Yu, 2002, The Journal of Biological Chemistry.

Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype.

L. Mitnaul, S. Wright, J. Menke, 2006, Biochemical pharmacology.

O-Arylmandelic Acids as Highly Selective Human PPAR α/γ Agonists.

A. Adams, 2003 .

Design of potent and selective GPR119 agonists for type II diabetes.

A. Howard, P. Meinke, G. Chicchi, 2011, Bioorganic & medicinal chemistry letters.

Reactive intermediates in the photochemistry of 4-diazo-2-pyrazolin-5-ones

S. Eḡe, A. Adams, P. Umrigar, 1984 .

Oxopyrazoline-spiro-oxirans. A new class of reactive heterocycles

D. Lankin, S. Eḡe, A. Adams, 1983 .

The structure and kinetic reactivity of a pyrrolidine-derived vinylogous urethane lithium enolate

J. Tata, A. Adams, R. H. Schlessinger, 1986 .

Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator.

Bruce A. Johnson, J. Berger, D. Moller, 2003, Molecular endocrinology.

L-764406 Is a Partial Agonist of Human Peroxisome Proliferator-activated Receptor γ

J. Berger, D. Moller, Gaochao Zhou, 1999, The Journal of Biological Chemistry.

Amphipathic 3-Phenyl-7-propylbenzisoxazoles; human pPaR γ, δ and α agonists

Joel P. Berger, J. Berger, D. Moller, 2003 .

Different roles of liver X receptor α and β in lipid metabolism: Effects of an α-selective and a dual agonist in mice deficient in each subtype

Qiu Guo, Jayne Chin, L. Mitnaul, 2006 .

Miniaturization of cell-based beta-lactamase-dependent FRET assays to ultra-high throughput formats to identify agonists of human liver X receptors.

L. Mitnaul, R. Lacson, J. Menke, 2003, Assay and drug development technologies.

SAR studies: designing potent and selective LXR agonists.

Jayne Chin, L. Mitnaul, Shaei Huang, 2006, Bioorganic & medicinal chemistry letters.

Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in Zucker diabetic fatty rats: A comparison with PPAR gamma agonism.

J. Berger, D. Moller, T. Doebber, 2006, Endocrinology.

Identification of a potent synthetic FXR agonist with an unexpected mode of binding and activation

J. W. Becker, S. Soisson, Alan D. Adams, 2008, Proceedings of the National Academy of Sciences.

Compound Characterization Using Gene Microarrays

D. Gerhold, R. Blevins, J. Berger, 2001 .

An approach to erythronolide A seco acid via a simple tetronic acid

J. Springer, A. Mjalli, K. Hoogsteen, 1992 .